⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer
businesswire.com
NVS
Global Telehealth Market is Projected to Cross the USD 2 Trillion Mark by 2034, Driven by Digital Healthcare Transformation | DelveInsight
prnewswire.com
TDOC
CSCO
PHG
IBM
MDT
AMWL
GEHC
HPQ
DOX
ISRG
BMBL
ADMA
FLEX
INTC
GOOG
MSFT
AMZN
NVDA
AAPL
TSLA
JNJ
PFE
ABBV
BMY
MRK
XRAY
SYK
BDX
LULU
ROST
ULTA
COST
MCHP
ON
ADI
TXN
QCOM
AMD
SIRI
CMCSA
VZ
T
MU
AMAT
KLAC
LRCX
WDC
SE
BABA
JD
NTES
PDD
IQ
BIDU
FOX
FOXA
NFLX
DIS
CMG
MCD
SBUX
YUM
CVS
EL
ORCL
CRM
NOW
ADBE
INTU
PAYX
ADP
MA
V
AXP
GS
JPM
BAC
WFC
MS
CME
ICE
SCHW
AMGN
GILD
REGN
BIIB
AZN
NVS
SNY
TEVA
CPRT
ALGN
EXPE
BKNG
MAR
HLT
IHG
WYNN
LVS
MGM
EXAS
ACAD
ALKS
VRTX
CRSP
EDIT
NTLA
NBIX
ALNY
BMRN
IDXX
ZBRA
HON
ETR
NEE
DUK
SO
XOM
CVX
SHEL
GOOGL
META
TMUS
AVGO
MRVL
NXPI
INFY
DELL
HPE
LEN
BRK.B
BRK.A
UNH
CI
CNC
ELV
HCA
EBS
TTWO
EA
NTDOY
SONY
GE
BA
GD
LMT
RTX
NOC
CAT
DE
AGCO
CNH
IRTC
HOLX
TNDM
PODD
RMD
MASI
SNOW
DDOG
PANW
FTNT
CRWD
OKTA
SNPS
CDNS
Dify Raises $30 million Series Pre-A to Power Enterprise-Grade Agentic Workflows
businesswire.com
ETS
NVS
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
globenewswire.com
NVS
Chronic Rhinosinusitis with Nasal Polyps Market Shows Strong Upward Momentum During the Forecast Period (2026-2036) as Demand for Advanced Therapies Rises | DelveInsight
prnewswire.com
GSK
UPB
SNY
LLY
AZN
AMGN
REGN
PFE
MRK
TEVA
NVS
INSM
LYRA
Paroxysmal Nocturnal Hemoglobinuria Market Enters Transition Phase as Second-Line Opportunities Expand Amid Ongoing Barriers to Adoption of Newer Agents, According to Spherix Global Insights
globenewswire.com
NVS
Les réformes réglementaires de l’UE et l’innovation mondiale dans le domaine des soins de santé seront au cœur de la conférence DIA Europe 2026
businesswire.com
AMGN
AZN
GSK
MRK
SNY
NVS
Les réformes réglementaires de l’UE et l’innovation mondiale dans le domaine des soins de santé seront au cœur de la conférence DIA Europe 2026
businesswire.com
AMGN
AZN
GSK
MRK
SNY
NVS
Regulatorische Reformen der EU und globale Innovationen im Gesundheitswesen stehen auf DIA Europe 2026 im Mittelpunkt
businesswire.com
AMGN
AZN
GSK
MRK
SNY
NVS
Regulatorische Reformen der EU und globale Innovationen im Gesundheitswesen stehen auf DIA Europe 2026 im Mittelpunkt
businesswire.com
AMGN
AZN
GSK
MRK
SNY
NVS